Authors: Washburn, WN Sher, PM Poss, KM Girotra, RN McCann, PJ Gavai, AV Mikkilineni, AB Mathur, A Cheng, P Dejneka, TC Sun, CQ Wang, TC Harper, TW Russell, AD Slusarchyk, DA Skwish, S Allen, GT Hillyer, DE Frohlich, BH Abboa-Offei, BE Cap, M Waldron, TL George, RJ Tesfamariam, B Ciosek, CP Ryono, D Young, DA Dickinson, KE Seymour, AA Arbeeny, CM Gregg, RE

Citation: Wn. Washburn et al., Beta 3 agonists. Part 1: Evolution from inception to BMS-194449, BIOORG MED, 11(23), 2001, pp. 3035-3039

Authors: Gavai, AV Sher, PM Mikkilineni, AB Poss, KM McCann, PJ Girotra, RN Fisher, LG Wu, G Bednarz, MS Mathur, A Wang, TC Sun, CQ Slusarchyk, DA Skwish, S Allen, GT Hillyer, DE Frohlich, BH Abboa-Offei, BE Cap, M Waldron, TL George, RJ Tesfamariam, B Harper, TW Ciosek, CP Young, DA Dickinson, KE Seymour, AA Arbeeny, CM Washburn, WN

Citation: Av. Gavai et al., BMS-196085: A potent and selective full agonist of the human beta(3) adrenergic receptor, BIOORG MED, 11(23), 2001, pp. 3041-3044

Authors: Tesfamariam, B Frohlich, BH Gregg, RE

Citation: B. Tesfamariam et al., Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+release and vascular reactivity, J CARDIO PH, 34(1), 1999, pp. 95-101

Authors: Tesfamariam, B Waldron, T Seymour, AA

Citation: B. Tesfamariam et al., Quantitation of tremor in response to beta-adrenergic receptor stimulationin primates: Relationship with hypokalemia, J PHARM TOX, 40(4), 1998, pp. 201-205